The prevalence of stromal myofibroblasts (i.e., αSMA-positive fibroblasts) in human breast cancers is related to aggressive adenocarcinomas and predicts human disease recurrence [66,67]. The gene discussed is ACTA1; the disease is adenocarcinoma.